Myocet-type non-PEGylated liposomal doxorubicin
EPC/cholesterol 55:45 liposomes with an acidic-citrate active-loading context for doxorubicin.
Applicable scenario
Composition reference for non-PEGylated liposomal doxorubicin and active loading of amphipathic weak bases. Useful as a comparison with PEGylated Doxil-type membranes.
Import to Workspace
Open or scan to import into Workspace, jump to Modules and open this Recipe in the editor.
Formulation tables
Non-PEGylated lipid membrane
| Component | Molar percentage | Role |
|---|---|---|
| EPC | 55 mol% | Acidic egg phosphatidylcholine membrane |
| Cholesterol | 45 mol% | Membrane composition |
Active-loading context
| Parameter | Value | Purpose |
|---|---|---|
| Internal citrate buffer | 300 mM, pH 4.0 | Blank-liposome hydration |
| External pH | Approximately 7.3 with sodium carbonate | Create loading conditions |
| Drug-to-lipid ratio | About 0.27 | Reviewed formulation |
| Diameter | 150–250 nm | Reviewed formulation context |
Source values and calculations
- The lipid molar ratio is EPC:cholesterol 55:45 as listed in Table 1.
- Blank liposomes use 300 mM citrate at pH 4.0; sodium carbonate raises the external pH to approximately 7.3 before doxorubicin incubation.
- The review reports a drug-to-lipid ratio of about 0.27 and liposomes of 150–250 nm.
Literature source
Bulbake U et al. Liposomal Formulations in Clinical Use: An Updated Review. Pharmaceutics 9, 12 (2017).
Source locator: Table 1, Myocet; Section 3.1.4, composition and active loading
Read the original source · DOI: 10.3390/pharmaceutics9020012
Editorial source check: 2026-11-09. Verify the original publication, actual stock concentrations and local safety requirements before use. Research use only; not clinical instructions.